[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-US6136810,2000,A
[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-US6136810,2000,A
Title: Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
Journal: European journal of pharmacology 20090521
Title: The type 4 phosphodiesterase inhibitors rolipram and YM976 facilitate recall of the weak version of the passive avoidance task in the day-old chick.
Journal: Pharmacology, biochemistry, and behavior 20090401
Title: [Effects of phosphodiesterase-4 inhibitor on the mucin secretion in airway stimulated with acrolein: experiment with rats].
Journal: Zhonghua yi xue za zhi 20081118
Title: The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
Journal: European journal of pharmacology 20060710
Title: Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle.
Journal: European journal of pharmacology 20030530
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs.
Journal: The Journal of pharmacology and experimental therapeutics 20010401
Title: A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity.
Journal: The Journal of pharmacology and experimental therapeutics 20001001